Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Silver. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7209689 | 0.86 | — | — | |
| Lithium Ion SCHEMBL3393433 | 0.86 | — | — | |
| SCHEMBL18189227 | 0.86 | — | — | |
| Potassium Ion SCHEMBL11290501 | 0.86 | — | — | |
| SCHEMBL17008162 | 0.86 | — | — | |
| SCHEMBL15709602 | 0.86 | — | — | |
| Potassium Ion SCHEMBL10399935 | 0.86 | — | — | |
| SCHEMBL11285652 | 0.86 | — | — | |
| Silver SCHEMBL9224201 | 0.57 | — | — | |
| SCHEMBL5797875 | 0.46 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3888649-B1 | CANNFLAVIN A FOR USE IN PROMOTING WOUND HEALING AND TREATING OR PREVENTING DIABETIC FEET | HANYI BIO TECH COMPANY LTD (CN) | 2023-08-09 | — | — | EP | claimed |
| US-20220079916-A1 | USE OF GERANYLFLAVONE A IN PREPARATION OF DRUG FOR PROMOTING HEALING OF WOUNDS | HANYI BIO-TECHNOLOGY COMPANY LTD. (CN) | 2022-03-17 | — | — | US | claimed |
| EP-3888649-A1 | USE OF GERANYLFLAVONE A IN PREPARATION OF DRUG FOR PROMOTING HEALING OF WOUNDS | Hanyi Bio-Technology Company Ltd. (CN) | 2021-10-06 | — | — | EP | claimed |
| US-10441664-B2 | Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent | MIMEDX GROUP, INC. (US) | 2019-10-15 | — | — | US | claimed |
| EP-2919858-B1 | CROSS-LINKED COLLAGEN WITH A BOUND ANTIMICROBIAL AGENT | MIMEDX GROUP INC (US) | 2019-05-15 | — | — | EP | claimed |
| US-20160184448-A1 | CROSS-LINKED COLLAGEN WITH AT LEAST ONE BOUND ANTIMICROBIAL AGENT FOR IN VIVO RELEASE OF THE AGENT | MIMEDX GROUP, INC. | 2016-06-30 | — | — | US | claimed |
| EP-1742530-B1 | ANTIMICROBIAL COATING FOR INHIBITION OF BACTERIAL ADHESION AND BIOFILM FORMATION | BACTERIN INT INC (US) | 2016-05-11 | — | — | EP | claimed |
| EP-2919858-A1 | CROSS-LINKED COLLAGEN WITH A BOUND ANTIMICROBIAL AGENT | MIMEDX Group Inc. (US) | 2015-09-23 | — | — | EP | claimed |
| US-20150010715-A1 | ANTIMICROBIAL COATING FOR INHIBITION OF BACTERIAL ADHESION AND BIOFILM FORMATION | BACTERIN (US) | 2015-01-08 | — | — | US | claimed |
| US-20140142025-A1 | Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent | MIMEDX GROUP, INC. (US) | 2014-05-22 | — | — | US | claimed |
| WO-2014078080-A1 | CROSS-LINKED COLLAGEN WITH A BOUND ANTIMICROBIAL AGENT | MIMEDX GROUP, INC. (US) | 2014-05-22 | — | — | WO | claimed |
| US-20080063693-A1 | Hydrogel and drug including a water insoluble antimicrobial metallic material solubilized within coating; drying hydrophilic polyfunctional polymer material layer; crosslinking to form a surface immobilized, three-dimensional hydrogel interpenetrating polymer network; medical equipment; catheters | BACTERIN INC. | 2008-03-13 | — | — | US | claimed |
| JP-2007535573-A | — | — | 2007-12-06 | — | — | JP | claimed |
| EP-1742530-A2 | ANTIMICROBIAL COATING FOR INHIBITION OF BACTERIAL ADHESION AND BIOFILM FORMATION | Bacterin International, Inc. (US) | 2007-01-17 | — | — | EP | claimed |
| WO-2005107455-A2 | ANTIMICROBIAL COATING FOR INHIBITION OF BACTERIAL ADHESION AND BIOFILM FORMATION | BACTERIN INTERNATIONAL, INC. (US) | 2005-11-17 | — | — | WO | claimed |
| EP-0241175-B1 | TOPICAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITION COMPRISING A SILVER COMPOUND AND AN AZOLE | SMITH & NEPHEW plc (GB) | 1990-12-27 | — | — | EP | claimed |
| EP-3755386-B1 | COMPOSITION HAVING EXCELLENT WATER VAPOR PERMEABILITY | URGO RECH INNOVATION ET DEVELOPPEMENT (FR) | 2023-09-13 | — | — | EP | disclosed |
| US-20230256140-A1 | ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES | MOZARC MEDICAL US LLC | 2023-08-17 | — | — | US | disclosed |
| US-4049802-A | Zinc sulfadiazine and its use in the treatment of burns | RESEARCH CORPORATION (US) | 1977-09-20 | — | — | US | disclosed |
| US-4020150-A | SYSTEMIC INFECTIONS, TUMORS | Ebert, Michael (US) | 1977-04-26 | — | — | US | disclosed |